target genes Search Results


86
Omics Data Automation target gene
Target Gene, supplied by Omics Data Automation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/target+genes/pm41166154-131-64-68?v=Omics+Data+Automation
Average 86 stars, based on 1 article reviews
target gene - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

90
PrimerDesign Inc primers targeting the mgf gene
Primers Targeting The Mgf Gene, supplied by PrimerDesign Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/target+genes/10__1016_slash_j__isci__2024__109050-108-21-27?v=PrimerDesign+Inc
Average 90 stars, based on 1 article reviews
primers targeting the mgf gene - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ACADEMIC PRESS INC gene targeting: a practical approach
Gene Targeting: A Practical Approach, supplied by ACADEMIC PRESS INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/target+genes/us08349567-95-12-4?v=ACADEMIC+PRESS+INC
Average 90 stars, based on 1 article reviews
gene targeting: a practical approach - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Synbio Technologies LLC dpo4 target gene
Dpo4 Target Gene, supplied by Synbio Technologies LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/target+genes/us10704031-25-1-15?v=Synbio+Technologies+LLC
Average 90 stars, based on 1 article reviews
dpo4 target gene - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma nox1 silencing sirnas targeting nox1 (403, 693, and 861 gene fragments)
Nox1 Silencing Sirnas Targeting Nox1 (403, 693, And 861 Gene Fragments), supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/target+genes/ppr0485631-95-0-14?v=Shanghai+GenePharma
Average 90 stars, based on 1 article reviews
nox1 silencing sirnas targeting nox1 (403, 693, and 861 gene fragments) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Targa GmbH targetable genes analysis
Targetable Genes Analysis, supplied by Targa GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/target+genes/pm36792093-32-14-19?v=Targa+GmbH
Average 90 stars, based on 1 article reviews
targetable genes analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Tetracore ez-sva real-time rt-pcr kit
Ez Sva Real Time Rt Pcr Kit, supplied by Tetracore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/target+genes/pm37764912-83-8-12?v=Tetracore
Average 90 stars, based on 1 article reviews
ez-sva real-time rt-pcr kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Targeted Genetics Corporation properties of gene transfer systems
Properties Of Gene Transfer Systems, supplied by Targeted Genetics Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/target+genes/pm16156012-45-8-2?v=Targeted+Genetics+Corporation
Average 90 stars, based on 1 article reviews
properties of gene transfer systems - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma sirna sequence targeting human pxr gene
Impact of <t>PXR</t> activation in DOX and PTX treated cells. (A) PXR mRNA expression with the treatment of DOX and PTX at 0, 4, 8, 12, 24, 36, 48 h. (B) Western blot analysis of PXR with 24 h treatment of DOX and PTX. **, p < 0.01 (n = 3). (C) RT-PCR analysis of PXR mRNA in PTX only (PTX) or treated cells exposed to transfection conditions in the absence <t>of</t> <t>siRNA</t> (mock) or cells transfected with non-targeting (NC) or PXR-specific siRNA (siRNA). (D) Comparison of MDR1 mRNA expression in the cells exposed to transfection conditions with 8 h/36 h DOX and PTX treatment. **, p < 0.01 (n = 3). (E) Rho-123 fluorescence ratio in the cells exposed to transfection conditions with 8 h/36 h DOX and PTX treatment. *, p < 0.05 (n = 3).
Sirna Sequence Targeting Human Pxr Gene, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/target+genes/pmc04279688-76-4-20?v=Shanghai+GenePharma
Average 90 stars, based on 1 article reviews
sirna sequence targeting human pxr gene - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
inGenious Targeting Laboratory loxp/frt-flanked neomycin phosphotransferase (neo r ) gene expression cassette
Impact of <t>PXR</t> activation in DOX and PTX treated cells. (A) PXR mRNA expression with the treatment of DOX and PTX at 0, 4, 8, 12, 24, 36, 48 h. (B) Western blot analysis of PXR with 24 h treatment of DOX and PTX. **, p < 0.01 (n = 3). (C) RT-PCR analysis of PXR mRNA in PTX only (PTX) or treated cells exposed to transfection conditions in the absence <t>of</t> <t>siRNA</t> (mock) or cells transfected with non-targeting (NC) or PXR-specific siRNA (siRNA). (D) Comparison of MDR1 mRNA expression in the cells exposed to transfection conditions with 8 h/36 h DOX and PTX treatment. **, p < 0.01 (n = 3). (E) Rho-123 fluorescence ratio in the cells exposed to transfection conditions with 8 h/36 h DOX and PTX treatment. *, p < 0.05 (n = 3).
Loxp/Frt Flanked Neomycin Phosphotransferase (Neo R ) Gene Expression Cassette, supplied by inGenious Targeting Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/target+genes/pmc04124536-44-2-35?v=inGenious+Targeting+Laboratory
Average 90 stars, based on 1 article reviews
loxp/frt-flanked neomycin phosphotransferase (neo r ) gene expression cassette - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AECOM International Development transgenic and gene targeting facility
Impact of <t>PXR</t> activation in DOX and PTX treated cells. (A) PXR mRNA expression with the treatment of DOX and PTX at 0, 4, 8, 12, 24, 36, 48 h. (B) Western blot analysis of PXR with 24 h treatment of DOX and PTX. **, p < 0.01 (n = 3). (C) RT-PCR analysis of PXR mRNA in PTX only (PTX) or treated cells exposed to transfection conditions in the absence <t>of</t> <t>siRNA</t> (mock) or cells transfected with non-targeting (NC) or PXR-specific siRNA (siRNA). (D) Comparison of MDR1 mRNA expression in the cells exposed to transfection conditions with 8 h/36 h DOX and PTX treatment. **, p < 0.01 (n = 3). (E) Rho-123 fluorescence ratio in the cells exposed to transfection conditions with 8 h/36 h DOX and PTX treatment. *, p < 0.05 (n = 3).
Transgenic And Gene Targeting Facility, supplied by AECOM International Development, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/target+genes/pmc03765320-150-5-5?v=AECOM+International+Development
Average 90 stars, based on 1 article reviews
transgenic and gene targeting facility - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Synbio Technologies LLC small interfering rnas targeting the thap11 gene coding sequence (cds) region
Impact of <t>PXR</t> activation in DOX and PTX treated cells. (A) PXR mRNA expression with the treatment of DOX and PTX at 0, 4, 8, 12, 24, 36, 48 h. (B) Western blot analysis of PXR with 24 h treatment of DOX and PTX. **, p < 0.01 (n = 3). (C) RT-PCR analysis of PXR mRNA in PTX only (PTX) or treated cells exposed to transfection conditions in the absence <t>of</t> <t>siRNA</t> (mock) or cells transfected with non-targeting (NC) or PXR-specific siRNA (siRNA). (D) Comparison of MDR1 mRNA expression in the cells exposed to transfection conditions with 8 h/36 h DOX and PTX treatment. **, p < 0.01 (n = 3). (E) Rho-123 fluorescence ratio in the cells exposed to transfection conditions with 8 h/36 h DOX and PTX treatment. *, p < 0.05 (n = 3).
Small Interfering Rnas Targeting The Thap11 Gene Coding Sequence (Cds) Region, supplied by Synbio Technologies LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/target+genes/pm40548980-82-1-18?v=Synbio+Technologies+LLC
Average 90 stars, based on 1 article reviews
small interfering rnas targeting the thap11 gene coding sequence (cds) region - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Impact of PXR activation in DOX and PTX treated cells. (A) PXR mRNA expression with the treatment of DOX and PTX at 0, 4, 8, 12, 24, 36, 48 h. (B) Western blot analysis of PXR with 24 h treatment of DOX and PTX. **, p < 0.01 (n = 3). (C) RT-PCR analysis of PXR mRNA in PTX only (PTX) or treated cells exposed to transfection conditions in the absence of siRNA (mock) or cells transfected with non-targeting (NC) or PXR-specific siRNA (siRNA). (D) Comparison of MDR1 mRNA expression in the cells exposed to transfection conditions with 8 h/36 h DOX and PTX treatment. **, p < 0.01 (n = 3). (E) Rho-123 fluorescence ratio in the cells exposed to transfection conditions with 8 h/36 h DOX and PTX treatment. *, p < 0.05 (n = 3).

Journal: Cancer Cell International

Article Title: Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells

doi: 10.1186/s12935-014-0142-4

Figure Lengend Snippet: Impact of PXR activation in DOX and PTX treated cells. (A) PXR mRNA expression with the treatment of DOX and PTX at 0, 4, 8, 12, 24, 36, 48 h. (B) Western blot analysis of PXR with 24 h treatment of DOX and PTX. **, p < 0.01 (n = 3). (C) RT-PCR analysis of PXR mRNA in PTX only (PTX) or treated cells exposed to transfection conditions in the absence of siRNA (mock) or cells transfected with non-targeting (NC) or PXR-specific siRNA (siRNA). (D) Comparison of MDR1 mRNA expression in the cells exposed to transfection conditions with 8 h/36 h DOX and PTX treatment. **, p < 0.01 (n = 3). (E) Rho-123 fluorescence ratio in the cells exposed to transfection conditions with 8 h/36 h DOX and PTX treatment. *, p < 0.05 (n = 3).

Article Snippet: The siRNA sequence targeting human PXR gene and the negative control that consisted of a non-complementary sequence were developed by GenePharma (Shanghai, China).

Techniques: Activation Assay, Expressing, Western Blot, Reverse Transcription Polymerase Chain Reaction, Transfection, Comparison, Fluorescence